companydata.dkcompanydata.dk

TRIO PHARMA ApS: Financial statements 2020

CVR: 36499281

Source: annual report 2020, Danish Business Authority

01/05/2019 – 30/04/2020

TRIO PHARMA ApS (CVR 36499281) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 84,547 and a net result of DKK -361,433 compared with DKK -232,267 the year before. That is a decrease of 36.9% compared with the year before. Equity in the 2020 report amounted to DKK -1,111,409. The company had 1 employee in the financial year.

Gross Profit
DKK 84,547
Profit/Loss
DKK -361,433
Equity
DKK -1,111,409
Total Assets
DKK 321,382
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-85 t.-361 t.-1.1 mio.1
2019-134 t.-232 t.-750 t.-
2018-28 t.-272 t.-518 t.-
2017--123 t.-244 t.-246 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is TRIO PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About TRIO PHARMA ApS

TRIO PHARMA ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christian Bo Ratje. The board consists of Michael John Ratje (chair), Christian Bo Ratje and Kirstine Laura Ratje-Johansen. The company is owned by STINE RATJE HOLDING ApS and CHRISTIAN RATJE HOLDING ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -411,555 and a net result of DKK -1,170,880 compared with DKK -489,664 the year before. Equity in the 2025 report amounted to DKK -2,593,533.

Source: annual report 2025, Danish Business Authority